A quiver full of vision

A quiver full of vision

We live in interesting times. Some would say challenging times, but then, it’s those very challenges which make it interesting. Take for instance, the fact that while most sectors are set for a slowdown, the Indian pharmaceutical industry is still hiring and clinical research institutes are reporting full placement of their students. That said, will the sector remain attractive enough for fresh talent? What are the emerging career options? How will global deals like the Pfizer- Wyeth merger and most recently the Pfizer-GSK JV in the HIV space impact job opportunities in the long run?

When Express Pharma decided to launch the first edition of the Pharma Bio Career Guide, we envisaged an initiative to bridge the gap between talent pools, industry and educational institutes which serve this vast sector. The industry is facing a tremendous talent crunch and in a knowledge driven sector, human assets are the hidden ‘Aces’ of any company. Therefore we approached industry leaders to analyse how these many changes would affect the industry. We got a quiver full of vision articles, teeming with insight and advice. We found that just as companies are morphing into new roles depending on changing business dynamics, fresh entrants into the industry as well as existing employees will need to keep an open mind and re-invent themselves.

Central to the rationale of this Guide is the fact that the only limiting factor to the growth of the Indian pharma industry is the dearth of talent. Poaching is rampant and attrition levels high. Companies will need to hone their HR processes to attract and retain the right ‘soft assets’ as this can make or break a company. Conversely, they will need to also learn to identify and get the wrong people ‘off the bus.’

This Guide also contains a handy listing of colleges and institutions. Academic institutes will have to re-jig their courses to offer students better value added content. The ones most in tune with industry needs seem to be clinical research institutes, as each academic year sees the introduction of more disciplines, be it pharmacovigilance or clinical data management. Yet other professionals will look at combining knowledge of finance or law, with their basic pharmacy or clinical research degrees.

So while our vision leaders fire their arrows of wisdom, we hope that they find the right target. Do write in with your suggestions on how we can take this initiative forward.

Viveka Roychowdhury